US 11098126
Anti-MET antibodies and uses thereof
granted A61KA61K2039/505A61P
Quick answer
US patent 11098126 (Anti-MET antibodies and uses thereof) held by AGOMAB THERAPEUTICS BVBA expires Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- AGOMAB THERAPEUTICS BVBA
- Grant date
- Tue Aug 24 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K2039/505, A61P, A61P1/00, A61P1/04